OptimizeRx (OPRX) Short Interest Ratio & Short Volume $13.55 +0.43 (+3.28%) As of 07/3/2025 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OptimizeRx Short Interest DataOptimizeRx (OPRX) has a short interest of 1.57 million shares, representing 9.37% of the float (the number of shares available for trading by the public). This marks a 1.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.4, indicating that it would take 5.4 days of the average trading volume of 301,355 shares to cover all short positions.Current Short Interest1,570,000 sharesPrevious Short Interest1,540,000 sharesChange Vs. Previous Month+1.95%Dollar Volume Sold Short$22.40 millionShort Interest Ratio5.4 Days to CoverLast Record DateJune 15, 2025Outstanding Shares18,500,000 sharesFloat Size16,750,000 sharesShort Percent of Float9.37%Today's Trading Volume78,613 sharesAverage Trading Volume301,355 sharesToday's Volume Vs. Average26% Short Selling OptimizeRx? Sign up to receive the latest short interest report for OptimizeRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPRX Short Interest Over TimeOPRX Days to Cover Over TimeOPRX Percentage of Float Shorted Over Time OptimizeRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,570,000 shares $22.40 million +2.0%9.4%5.4 $14.27 5/31/20251,540,000 shares $18.77 million -6.1%8.9%2.5 $12.19 5/15/20251,640,000 shares $17.47 million -10.4%9.5%2.9 $10.65 4/30/20251,830,000 shares $16.69 million +5.2%N/A3.6 $9.12 4/15/20251,740,000 shares $14.49 million +4.8%10.1%3.5 $8.33 3/31/20251,660,000 shares $14.38 million -3.5%10.7%3.3 $8.66 3/15/20251,720,000 shares $13.36 million +22.0%11.1%3.4 $7.77 2/28/20251,410,000 shares $7.30 million +6.8%9.0%7 $5.18 2/15/20251,320,000 shares $8.76 million +3.1%8.4%5.7 $6.64 1/31/20251,280,000 shares $7.10 million +4.9%8.1%4.3 $5.55 Get the Latest News and Ratings for OPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,220,000 shares $6.03 million -1.6%7.8%4.1 $4.94 12/31/20241,240,000 shares $6.03 million +12.7%7.9%4.1 $4.86 12/15/20241,100,000 shares $5.49 million +10.0%6.9%4 $4.99 11/30/20241,000,000 shares $5.45 million -5.7%6.3%4.2 $5.45 11/15/20241,060,000 shares $4.05 million +10.8%6.6%5 $3.83 10/31/2024956,300 shares $4.99 million +4.8%6.0%7.4 $5.22 10/15/2024912,500 shares $5.93 million +8.7%5.8%7.2 $6.50 9/30/2024839,400 shares $6.48 million -2.9%5.3%6.9 $7.72 9/15/2024864,500 shares $6.74 million +0.1%5.4%7.2 $7.80 8/31/2024863,700 shares $7.18 million -8.2%5.4%7.4 $8.31 8/15/2024941,000 shares $7.90 million +1.0%5.9%7.9 $8.40 7/31/2024931,700 shares $10.16 million -7.8%5.9%7.1 $10.91 7/15/20241,010,000 shares $10.39 million No Change6.4%7.5 $10.29 6/30/20241,010,000 shares $10.10 million -1.0%6.4%7.4 $10.00 6/15/20241,020,000 shares $11.22 million -1.0%6.4%7.3 $11.00 5/31/20241,030,000 shares $12.42 million +12.5%6.4%6.7 $12.06 5/15/2024916,000 shares $12.06 million +12.7%5.7%6 $13.17 4/30/2024812,500 shares $8.29 million +29.7%5.1%6.1 $10.20 4/15/2024626,600 shares $6.47 million -4.5%3.9%5.2 $10.32 3/31/2024656,000 shares $7.97 million -13.1%4.1%5.5 $12.15 3/15/2024754,700 shares $9.58 million -3.3%4.7%6.4 $12.69 2/29/2024780,500 shares $12.36 million +0.3%4.9%5.6 $15.83 2/15/2024778,200 shares $12.38 million -0.1%4.9%5.5 $15.91 1/31/2024778,800 shares $11.00 million -19.6%4.9%4.8 $14.12 1/15/2024968,400 shares $14.31 million +1.3%6.1%5.4 $14.78 12/31/2023956,300 shares $13.68 million -0.1%6.0%5.1 $14.31 12/15/2023957,200 shares $10.56 million -1.0%6.0%5.2 $11.03 11/30/2023967,100 shares $9.20 million +5.0%N/A6.1 $9.51 11/15/2023921,300 shares $8.88 million +5.7%N/A5.2 $9.64 10/31/2023871,400 shares $7.02 million +10.7%N/A4.5 $8.06Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 10/15/2023787,000 shares $6.68 million +7.6%5.0%4.7 $8.49 9/30/2023731,300 shares $5.69 million +8.1%4.6%5 $7.78 9/15/2023676,600 shares $5.66 million +8.3%4.2%4.7 $8.37 8/31/2023624,800 shares $5.32 million -11.2%3.9%4.6 $8.52 8/15/2023703,200 shares $6.39 million -4.3%4.4%5.6 $9.08 7/31/2023734,600 shares $10.25 million +2.8%4.5%6.9 $13.95 7/15/2023714,700 shares $10.53 million -3.1%4.3%6.3 $14.74 6/30/2023737,900 shares $10.54 million -10.9%4.5%6.1 $14.29 6/15/2023827,700 shares $12.43 million +14.6%5.1%6.2 $15.02 5/31/2023722,100 shares $10.14 million +1.6%4.4%3 $14.04 5/15/2023710,500 shares $9.29 million -19.7%4.3%2.8 $13.08 4/30/2023884,500 shares $13.29 million -3.7%5.4%3.6 $15.03 4/15/2023918,000 shares $13.23 million -14.2%5.6%3.7 $14.41 3/31/20231,070,000 shares $15.65 million -24.7%6.6%4.2 $14.63 3/15/20231,420,000 shares $18.37 million -4.7%8.7%5.6 $12.94 2/28/20231,490,000 shares $26.60 million -6.3%9.1%8.2 $17.85 2/15/20231,590,000 shares $29.03 million +3.3%9.7%11 $18.26 1/31/20231,540,000 shares $27.64 million +29.4%9.4%8.7 $17.95 1/15/20231,190,000 shares $22.04 million +3.5%7.3%6.5 $18.52 12/30/20221,150,000 shares $19.32 million +8.5%7.0%6.1 $16.80 12/15/20221,060,000 shares $18.56 million +3.9%6.5%5.4 $17.51 11/30/20221,020,000 shares $21.51 million -9.7%6.2%5.1 $21.09 11/15/20221,130,000 shares $24.91 million +2.7%6.9%5.4 $22.04 10/31/20221,100,000 shares $16.96 million +0.9%N/A4.2 $15.42 10/15/20221,090,000 shares $15.01 million +11.2%6.6%4.1 $13.77 9/30/2022980,000 shares $14.52 million -1.7%5.9%3.5 $14.82 9/15/2022996,800 shares $15.53 million +3.7%6.0%3.6 $15.58 8/31/2022961,500 shares $15.26 million -10.1%6.1%3.7 $15.87 8/15/20221,070,000 shares $16.69 million -12.3%6.7%4.3 $15.60 7/31/20221,220,000 shares $27.41 million -12.9%7.7%6.4 $22.47 7/15/20221,400,000 shares $41.10 million -4.1%8.8%7.1 $29.36 6/30/20221,460,000 shares $39.99 million +13.2%15.2%8.2 $27.39 6/15/20221,290,000 shares $34.31 million +5.7%13.4%7.2 $26.60 5/31/20221,220,000 shares $31.21 million +9.9%7.7%7 $25.58 5/15/20221,110,000 shares $27.88 million -3.5%7.0%6 $25.12 4/30/20221,150,000 shares $32.33 million -17.3%7.2%6.1 $28.11 4/15/20221,390,000 shares $54.13 million -5.4%8.9%7.7 $38.94 3/31/20221,470,000 shares $55.43 million -9.3%9.4%7.4 $37.71 3/15/20221,620,000 shares $59.44 million +14.9%10.4%7.3 $36.69 2/28/20221,410,000 shares $63.86 million +19.5%9.0%5.6 $45.29 2/15/20221,180,000 shares $57.38 million -1.7%7.6%4.5 $48.63 1/31/20221,200,000 shares $53.92 million +0.8%7.7%4.3 $44.93 1/15/20221,190,000 shares $59.12 million -7.0%7.7%4.3 $49.68 12/31/20211,280,000 shares $79.50 million +3.2%8.2%4.9 $62.11 12/15/20211,240,000 shares $68.91 million -15.1%8.0%3.3 $55.57 11/30/20211,460,000 shares $94.90 million -0.7%9.4%4 $65.00 11/15/20211,470,000 shares $117.73 million -13.0%9.5%4.2 $80.09 10/29/20211,690,000 shares $163.42 million -1.7%11.0%5.4 $96.70 10/15/20211,720,000 shares $145.55 million +35.4%11.2%5.4 $84.62 9/30/20211,270,000 shares $108.65 million +19.8%8.3%4.2 $85.55Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/15/20211,060,000 shares $71.00 million -2.8%6.9%6.3 $66.98 8/31/20211,090,000 shares $72.14 million +9.7%7.1%7.3 $66.18 8/13/2021994,100 shares $61.75 million +13.1%6.5%6.7 $62.12 7/30/2021879,000 shares $48.58 million -2.8%5.8%5.7 $55.27 7/15/2021904,400 shares $46.06 million -2.0%6.0%6.1 $50.93 6/30/2021923,200 shares $57.15 million +5.1%6.6%5.8 $61.90 6/15/2021878,500 shares $45.75 million -3.3%5.9%5 $52.08 5/28/2021908,600 shares $44.63 million -3.7%6.1%4.4 $49.12 5/14/2021943,800 shares $40.36 million -3.0%N/A3.9 $42.76 4/30/2021972,800 shares $48.85 million -2.6%N/A3.3 $50.22 4/15/2021999,200 shares $50.16 million -1.1%N/A3.4 $50.20 3/31/20211,010,000 shares $46.84 million +13.9%N/A3.4 $46.38 3/15/2021887,100 shares $40.18 million +1.9%N/A3.1 $45.29 2/26/2021871,000 shares $48.78 million -6.4%N/A3.4 $56.01 2/12/2021930,300 shares $50.21 million -9.7%N/A4.3 $53.97 1/29/20211,030,000 shares $48.65 million +4.2%8.2%5.5 $47.23 1/15/2021988,900 shares $39.55 million +7.1%7.9%6.3 $39.99 12/31/2020923,400 shares $28.81 million -4.9%7.5%6.1 $31.20 12/15/2020971,000 shares $28.37 million -10.9%7.8%5.7 $29.22 11/30/20201,090,000 shares $27.41 million -7.6%8.8%6.3 $25.15 11/15/20201,180,000 shares $28.74 million -1.7%9.5%7 $24.36 10/30/20201,200,000 shares $24.20 million -3.2%9.7%7.3 $20.17 10/15/20201,240,000 shares $26.90 million +3.3%10.1%7.2 $21.69 9/30/20201,200,000 shares $25.02 million +3.5%9.8%7.4 $20.85 9/15/20201,160,000 shares $23.49 million -3.3%9.6%8.5 $20.25 8/31/20201,200,000 shares $24.19 million -4.0%9.9%8.7 $20.16 8/14/20201,250,000 shares $22 million +21.4%10.3%8.5 $17.60 7/31/20201,030,000 shares $14.57 million +1.0%8.5%7.4 $14.15 7/15/20201,020,000 shares $15.24 million -1.9%8.5%7.7 $14.94 OPRX Short Interest - Frequently Asked Questions What is OptimizeRx's current short interest? Short interest is the volume of OptimizeRx shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 1,570,000 shares of OPRX short. 9.37% of OptimizeRx's shares are currently sold short. Learn More on OptimizeRx's current short interest. What is a good short interest ratio for OptimizeRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPRX shares currently have a short interest ratio of 5.0. Learn More on OptimizeRx's short interest ratio. Which institutional investors are shorting OptimizeRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of OptimizeRx: Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for OptimizeRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.37% of OptimizeRx's floating shares are currently sold short. Is OptimizeRx's short interest increasing or decreasing? OptimizeRx saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,570,000 shares, an increase of 1.9% from the previous total of 1,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OptimizeRx's float size? OptimizeRx currently has issued a total of 18,500,000 shares. Some of OptimizeRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptimizeRx currently has a public float of 16,750,000 shares. How does OptimizeRx's short interest compare to its competitors? 9.37% of OptimizeRx's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to OptimizeRx: Telus Digital (5.23%), Emerald Holding, Inc. (5.60%), Ibotta, Inc. (13.67%), NeoGenomics, Inc. (3.43%), Willdan Group, Inc. (3.32%), Next Technology Holding Inc. (0.09%), i3 Verticals, Inc. (14.71%), NerdWallet, Inc. (5.25%), Riskified Ltd. (1.24%), Paysafe Limited (6.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short OptimizeRx stock? Short selling OPRX is an investing strategy that aims to generate trading profit from OptimizeRx as its price is falling. OPRX shares are trading up $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptimizeRx? A short squeeze for OptimizeRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OPRX, which in turn drives the price of the stock up even further. How often is OptimizeRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPRX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TIXT Short Squeeze EEX Short Squeeze IBTA Short Squeeze NEO Short Squeeze WLDN Short Squeeze NXTT Short Squeeze IIIV Short Squeeze NRDS Short Squeeze RSKD Short Squeeze PSFE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPRX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
